Simulations Guide Rapid Engineering Of New Functions In Mammalian Cells

Simulations Guide Rapid Engineering Of New Functions In Mammalian Cells

A change of instructions in a computer program directs the computer to execute a different command. Similarly, synthetic biologists are learning the rules for how to direct the activities of human cells.  “Cells are intricate machines that have evolved many interacting circuits—sets of genes that coordinate functions like migration, metabolism, and cell division,” explains David … Read more

Startup Dyno Therapeutics Applies AI To Gene Therapy

Startup Dyno Therapeutics Applies AI To Gene Therapy

Dyno Therapeutics applies artificial intelligence (AI) and quantitative in vivo experiments to gene therapy. The company’s proprietary CapsidMap™ platform discovers and systematically optimizes Adeno-Associated Virus (AAV) capsid vectors that is designed to outperform current approaches for in vivo gene delivery, thereby expanding the range of diseases treatable with gene therapies. In a paper published recently … Read more

NASA’s Plans Involving Synthetic Biology

NASA’s Plans Involving Synthetic Biology

NASA is investigating two potential applications of synthetic biology—one to advance nutrition and one to increase in-space manufacturing capabilities. Astronauts aboard the International Space Station receive regular resupply shipments from Earth, providing them with nutritious food during their expeditions. Future astronauts on the journey to Mars will be much farther away, outside the reach of … Read more

IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

Verve Therapeutics, a biotech company innovating new approaches to the care of cardiovascular disease with single-course gene editing medicines, announced terms for its $201 million IPO on today. Insiders Wellington Management and Casdin Capital and new investor Fidelity have indicated an interest in purchasing up to an aggregate $75 million worth of shares in the … Read more

Liquid Biopsy Rapidly Moves From Companion Diagnostic To A Cancer Screening Tool

Liquid Biopsy Rapidly Moves From Companion Diagnostic To A Cancer Screening Tool

In October 2020, the Food and Drug Administration (FDA) approved two blood tests, known as liquid biopsies, that can help guide treatment decisions for people with cancer. The tests, Guardant360 CDx and FoundationOne Liquid CDx, are made by different companies and were approved separately. Doctors have traditionally based treatment decisions on features like the organ … Read more